Latest research report on “Meningococcal Vaccine Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5552933
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
This report contains market size and forecasts of Meningococcal Vaccine in global, including the following market information:
Global Meningococcal Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Meningococcal Vaccine Market Sales, 2017-2022, 2023-2028, (10K Pcs)
Global top five Meningococcal Vaccine companies in 2021 (%)
The global Meningococcal Vaccine market was valued at 269.6 million in 2021 and is projected to reach US$ 359.8 million by 2028, at a CAGR of 4.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Meningtits A Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Meningococcal Vaccine include Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med and China National Biotec Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Meningococcal Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Meningococcal Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (10K Pcs)
Global Meningococcal Vaccine Market Segment Percentages, by Type, 2021 (%)
– Meningtits A
– Polysaccharide Meningtitis AC
– Meningitis ACYW
Global Meningococcal Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (10K Pcs)
Global Meningococcal Vaccine Market Segment Percentages, by Application, 2021 (%)
– 6 Months-15Year
– over 3 Year
– over 2 Year
– over 3 Months
Global Meningococcal Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (10K Pcs)
Global Meningococcal Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– Europe
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– Asia
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Meningococcal Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Meningococcal Vaccine revenues share in global market, 2021 (%)
Key companies Meningococcal Vaccine sales in global market, 2017-2022 (Estimated), (10K Pcs)
Key companies Meningococcal Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– Novartis
– GSK
– Merck
– CSL
– Baxter
– JN International Medical Corporation
– Serum Institute of India
– Bio-Med
– China National Biotec Group
– Hualan Bio
– Walvax
– Zhifei
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5552933
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441